Practitioners need corporate compliance education: AAO–HNS survey results
Received 25 June 2009; received in revised form 25 September 2009; accepted 14 October 2009.
Abstract
The environment in which otolaryngologists coexist with device and drug development has become increasingly complex. There are broad implications for both the academic and the private practitioner, with neither group being more or less insulated than the other. From the medical, ethical, and resource-oriented standpoints, otolaryngologists must consider this evolving area very carefully. A survey of the American Association of Otolaryngology–Head and Neck Surgery membership identified areas of education to improve the awareness and knowledge base of these complex considerations. In particular, knowledge of legal proceedings, Food and Drug Administration processes, relevant hospital resources, and conflict of interest considerations were areas in which the membership would benefit from further instruction.
aDepartments of Otolaryngology–Head and Neck Surgery, and Neurological Surgery, Boston University School of Medicine, Boston, MA
bHudson Valley Ear, Nose and Throat PC, Middletown, NY
cMedical Devices and Drugs Committee, American Academy of Otolaryngology–Head and Neck Surgery Foundation, Chicago, IL
dNemours/Alfred I. duPont Hospital for Children, Wilmington, DE
eJefferson Medical College, Thomas Jefferson University, Philadelphia, PA
Corresponding author: Udayan K. Shah, MD, Division of Otolaryngology, 1600 Rockland Rd, Wilmington, DE 19803
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
ABSTRACT